KK
US • —
$0.00
P/E
22.73
PEG
0.89
FCF Yield
—
Rev Growth YoY
-6.4% YoY
Gross Margin
36.0%
Health Score
5/10
D/E Ratio
1.52
Confidence
MEDIUM
Business Snapshot
This company operates within its sector but specific business details, primary revenue-generating products, and market position cannot be determined from the available data. The market capitalisation tier and precise financial scale are unavailable from the provided information. The trailing twelve-month revenue figure is not reported, while earnings show a growth rate of 25.6%. A defining characteristic cannot be identified from the limited data provided.
Financial Health
The gross margin stands at 36.0%, but a prior year comparison is not available for trend assessment. The net margin is a reasonable 10.6%, indicating the company retains a moderate portion of revenue as profit after all expenses...
Risk Assessment
- REVENUE DECELERATION — Revenue is declining by 6.4% year-over-year, a clear sign of top-line contraction.
- DEBT / LIQUIDITY — Debt/equity of 1.52x is elevated, and a current ratio of 0.81x indicates a potential liquidity shortfall.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- ANALYST SENTIMENT — Analysts are overwhelmingly cautious, with 0% buy ratings and 81% hold ratings, reflecting limited Wall Street support.
- INSIDER ACTIVITY — Insider activity over the last 90 days shows a net sell signal, with 0 buys versus 1 sell....
The gross margin stands at 36.0%, but a prior year comparison is not available for trend assessment. The net margin is a reasonable 10.6%, indicating the company retains a moderate portion of revenue as profit after all expenses. The balance sheet shows a debt/equity ratio of 1.52x, which is elevated and suggests a leveraged capital structure, while the current ratio of 0.81x signals potential near-term liquidity pressure as current liabilities exceed current assets. Return on equity is strong at 31.9%, implying efficient use of shareholder equity to generate profits. Free cash flow and FCF yield are not reported, making it impossible to assess the company's ability to self-fund operations, pay dividends, or reduce debt; this lack of cash flow visibility is a concern.
- REVENUE DECELERATION — Revenue is declining by 6.4% year-over-year, a clear sign of top-line contraction. - DEBT / LIQUIDITY — Debt/equity of 1.52x is elevated, and a current ratio of 0.81x indicates a potential liquidity shortfall. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - ANALYST SENTIMENT — Analysts are overwhelmingly cautious, with 0% buy ratings and 81% hold ratings, reflecting limited Wall Street support. - INSIDER ACTIVITY — Insider activity over the last 90 days shows a net sell signal, with 0 buys versus 1 sell.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives